Exploring Dermata Therapeutics’ Stock Surge
Exploring Dermata Therapeutics’ Stock Surge
Dermata Therapeutics Inc DRMA stock was trading higher Friday after the company announced the issuance of a new patent in Japan for its DMT410 program for hyperhidrosis (excessive sweating that’s not always related to heat or exercise). The patent, entitled “Compositions for the treatment of skin conditions” (Japanese Patent No. 7395576), further strengthens Dermata’s intellectual property for DMT410 ...












